The popularity of foreign-made pharmaceuticals in China continues to rise, with imports and joint-venture products accounting for one-third of the Chinese pharmaceutical markets. In some areas of China, especially Guangdong province (which neighbors Hong Kong), foreign-made pharmaceuticals can account for as much... Read More
Medical devices were not required to be formally registered for sale in China until late 1994. Since then, however, several regulations with regard to the import and sale of medical devices have been implemented. The State Drug Administration (SDA) is the central... Read More
China’s $22.5 billion pharmaceutical market is the second largest in Asia, after Japan, and foreign drug imports and pharmaceutical investment in China will likely increase as China enters the WTO. Anticipating an influx of foreign pharmaceuticals, the Chinese government established the State... Read More
Regulations for medical devices vary by country in Asia and are always changing. India and Malaysia, which previously did not have regulations for product registration, have recently adopted stricter and more comprehensive guidelines. In Taiwan, where registration rules were different for domestic... Read More
Once severely restrictive in practice and economically limited, markets in China are beginning to hold brighter prospects for successful entry by foreign manufacturers and suppliers. Medical product companies looking for product import, distribution and manufacturing opportunities in China will find promise in... Read More
Currently, China's medical device market is worth about $1.4 billion. As this market continues to grow, more and more foreign medical device companies will look for ways to expand into China. This article discusses business strategies available to these companies setting up... Read More
China's pharmaceutical market is the second largest in Asia, worth $22.5 billion, and will likely increase upon China's entrance into the WTO. In March 1998, the Chinese government created the State Drug Administration (SDA) to oversee drug importation, improving the enforcement and... Read More
China's medical device market is one of the largest in the world, and with China's accession to the WTO, foreign medical companies have an even greater opportunity to enter this fast-expanding market. As people in China continue to demand better healthcare, the... Read More
China's pharmaceutical market is booming, and with the formation of the State Drug Administration (SDA) in 1998, enforcement of pharmaceutical regulations has greatly improved. An increase in drug supervision, through stricter punishments for drug research, declaration and registration violations, was implemented by... Read More
Recovering economies throughout Asia offer promising markets for foreign medical device firms as well as opportunities for local product development and manufacturing. Before the Asian financial crisis, regional medical device markets grew at double-digit rates. Patients wanted the technologically innovative, cost-effective devices... Read More